Stellus Capital Investment (NYSE:SCM – Get Free Report) had its price target reduced by stock analysts at LADENBURG THALM/SH SH from $11.00 to $10.50 in a report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the investment management company’s stock. LADENBURG THALM/SH SH’s target price would indicate a potential upside of 20.83% from the company’s previous close.
SCM has been the topic of a number of other reports. Weiss Ratings lowered Stellus Capital Investment from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, July 28th. Keefe, Bruyette & Woods reduced their price objective on shares of Stellus Capital Investment from $9.00 to $8.00 and set a “market perform” rating for the company in a research report on Monday, July 20th. Zacks Research raised shares of Stellus Capital Investment from a “strong sell” rating to a “hold” rating in a research report on Friday, May 15th. Finally, Wall Street Zen raised shares of Stellus Capital Investment from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $9.25.
View Our Latest Stock Report on SCM
Stellus Capital Investment Stock Down 1.3%
Stellus Capital Investment (NYSE:SCM – Get Free Report) last released its quarterly earnings data on Monday, August 10th. The investment management company reported $0.26 EPS for the quarter, meeting the consensus estimate of $0.26. Stellus Capital Investment had a return on equity of 9.07% and a net margin of 30.66%.The company had revenue of $30.98 million during the quarter, compared to the consensus estimate of $24.38 million. As a group, research analysts anticipate that Stellus Capital Investment will post 1.05 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, Director J Tim Arnoult purchased 9,000 shares of Stellus Capital Investment stock in a transaction that occurred on Tuesday, May 19th. The stock was acquired at an average cost of $9.05 per share, for a total transaction of $81,450.00. Following the purchase, the director directly owned 50,869 shares of the company’s stock, valued at $460,364.45. This trade represents a 21.50% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 4.24% of the company’s stock.
Hedge Funds Weigh In On Stellus Capital Investment
Several institutional investors and hedge funds have recently modified their holdings of the business. Geneos Wealth Management Inc. acquired a new stake in Stellus Capital Investment in the 2nd quarter worth about $25,000. Laurel Wealth Advisors LLC bought a new position in shares of Stellus Capital Investment during the fourth quarter worth approximately $26,000. JPMorgan Chase & Co. acquired a new stake in shares of Stellus Capital Investment in the third quarter valued at approximately $28,000. BNP Paribas Financial Markets bought a new stake in shares of Stellus Capital Investment in the second quarter valued at approximately $60,000. Finally, Kestra Advisory Services LLC bought a new stake in shares of Stellus Capital Investment in the fourth quarter valued at approximately $62,000. 13.22% of the stock is currently owned by institutional investors and hedge funds.
Stellus Capital Investment Company Profile
Stellus Capital Investment Corporation (NYSE: SCM) is a closed-end, externally managed business development company that provides debt and equity financing to middle market companies in the United States. As an investment vehicle specializing in private credit, Stellus focuses on originating and structuring senior secured loans, unitranche facilities, mezzanine debt, and equity co-investments tailored to the unique needs of growing businesses. Its flexible capital solutions are designed to support acquisitions, recapitalizations, growth initiatives, and balance sheet refinancings.
Operating under an evergreen structure, Stellus Capital Investment partners with a diverse group of portfolio companies across industries such as manufacturing, healthcare, business services, and specialty finance.
Further Reading
- Five stocks we like better than Stellus Capital Investment
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
- Intel’s Rally Gave It a $20 Billion Opportunity and Now Comes the Hard Part
Receive News & Ratings for Stellus Capital Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stellus Capital Investment and related companies with MarketBeat.com's FREE daily email newsletter.
